Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
The healthcare reform measure passed by the US House of Representatives delivers some good news for drugmakers, device companies and even health insurers. Among the changes in the legislation was a provision delaying hefty taxes on those three industrie Full Article at TVNZ
Jade Goody’s death a year ago raised awareness of cervical cancer among young women. Gareth Cattermole / Getty Images One year ago today, the British reality television star Jade Goody died from cervical cancer, leaving behind her husband and two sons. Full Article at The National Newspaper
This undated photo provided by Merial shows Frontline products. Frontline is sold by Sanofi-Aventis SA. The French company and New jersey's Merck & Co. plan to combine their animal health business in a joint venture. View Photo »
In his 1995 annual letter to shareholders, Merck's chairman and CEO, Ray Gilmartin, delineated the company's number-one business objective as 'being a top-tier growth company'
This declining company lost patent protection for its statin, Zocor. It has replaced some of these sales with three new drugs, but, in reality, they cannot make up for the lost revenue from Zocor. Merck's (MRK) revenues are stagnant and the company has Full Article at Blogging Stocks
Schering-Plough Corp. was in trouble. The New Jersey-based pharmaceutical and consumer products company, home of the allergy meds Nasonex and Claritin, was hemorrhaging market share in 2003, seeing its profits fall and facing costly manufacturing and co Full Article at Rochester Democrat and Chronicle
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPick Full Article at SocialPicks
CENTURY CITY, CA - JANUARY 30: Director Zach Merck (R) and Amanda Merck arrive at the 62nd Annual Directors Guild Of America Awards at the Hyatt Regency Century Plaza on January 30, 2010 in Century City, California. View Photo »
Merck is making use of the currently good climate for corporate bonds
Get free personalized health guidance for you and your family. Free e-newsletters Mayo Clinic expertise We do not share your e-mail address Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with Full Article at Mayo Clinic
Get free personalized health guidance for you and your family. Free e-newsletters Mayo Clinic expertise We do not share your e-mail address Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with Full Article at Mayo Clinic
There are no results for this module. Edit this module to change the search term used to query Wikipedia
CENTURY CITY, CA - JANUARY 30: Director Zach Merck (R) and Amanda Merck arrive at the 62nd Annual Directors Guild Of America Awards at the Hyatt Regency Century Plaza on January 30, 2010 in Century City, California.
View Photo »Richard Clark, Chairman and CEO of Merck attends a session at the World Economic Forum (WEF) in Davos January 29, 2010.
View Photo »This undated photo provided by Merial shows Frontline products. Frontline is sold by Sanofi-Aventis SA. The French company and New jersey's Merck & Co. plan to combine their animal health business in a joint venture.
View Photo »FILE - In this June 17, 2005 file photo, Merck & Co. CEO Richard T. Clark, answers a question at the drug maker's Whitehouse Station, N.J. headquarters. Clark said Monday, Aug. 31, 2009, the company will restructure into five divisions after it completes the buyout of rival...
View Photo »Richard Clark, Chairman, President and Chief Executive Officer of Merck & Co. , Inc. , speaks at the Reuters Health Summit in New York, November 10, 2009.
View Photo »In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. Shareholders of the two companies on Friday, Aug. 7, 2009 both overwhelmingly backed a huge tie-up of the New Jersey...
View Photo »File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. Drugmaker Merck & Co. on Tuesday, Feb. 16, 2010 posted huge jumps in revenue and profit for the fourth quarter,...
View Photo »File - In this combo made from file photos, the company logos for drugmakers Merck & Co. and Schering-Plough Corp. are seen outside the companies' New Jersey headquarters. The European Union on Friday Oct. 23, 2009 approved the proposed tie-up of U.S. drug makers Merck & Co. and...
View Photo »FILE - In this 2004 file photo provided by Schering-Plough Corp. , the cholesterol-lowering drug Vytorin, the product of a joint venture between pharmaceutical companies Merck & Co. , and Schering-Plough Corp. , is shown. Drug developers Merck & Co. and Schering-Plough Corp. said...
View Photo »In this May 22, 2008 file photo, the company logo is seen on the doors of a building at Merck & Co. headquarters in Whitehouse Station, N.J. Drugmaker Merck & Co. on Tuesday, July 21, 2009, posted a 12 percent drop in second-quarter profit, due to lower sales of its cholesterol drugs and...
View Photo »In this Sept. 30, 2004 file photo, Vioxx is arranged on a counting tray, laying on top of the bottle, at The Pennington Apothecary in a Pennington, N.J. The U.S. Supreme Court will decide whether shareholders can sue international pharmaceutical maker Merck & Co. because of the...
View Photo »FILE - In this Nov. 9, 2009, file photo, a package of the H1N1 swine flu vaccine is shown at a pharmacy in Seattle. Last fall, as swine flu cases mounted and parents desperately sought to protect their kids, the hard-to-get vaccine was handed out in some surprising places: the Royal...
View Photo »WASHINGTON - MAY 11: U.S. President Barack Obama (C) delivers remarks about health care reform with (L-R) Cedars-Sinai Health System President and CEO Tom Priselac; Merck Chairman, President and CEO Richard Clark; Kaiser Permanente CEO George Halverson; American Medical Association...
View Photo »WASHINGTON - MAY 11: U.S. President Barack Obama (L) departs after delivering remarks about health care reform with (L-R) Cedars-Sinai Health System President and CEO Tom Priselac; Merck Chairman, President and CEO Richard Clark; Kaiser Permanente CEO George Halverson; and American...
View Photo »This Dec. 2007 photo provided by the American Society for the Prevention of Cruelty to Animals shows Dr. Melinda Merck examining the eyes of a puppy at a veterinary clinic in New York. The University of Florida and the American Society for the Prevention of Cruelty to Animals are...
View Photo »In the April 15, 2009 photo, people are seen as they walk along a hallway past large signs at Merck & Company, Inc.'s world headquarters in Whitehouse Station, N.J. Drugmaker Merck & Co. on Tuesday, April 21, posted a 57 percent drop in first-quarter profit, falling short of expectations,...
View Photo »In this April 15, 2009 photo, Richard T. Clark, Chairman, President and Chief Executive Officer of Merck & Company, Inc. , is seen at the company's world headquarters in Whitehouse Station, N.J. Drugmaker Merck & Co. on Tuesday, April 21, posted a 57 percent drop in first-quarter profit,...
View Photo »In this April 15, 2009 photo, a security guard stands in the lobby of Merck & Company, Inc.'s world headquarters in Whitehouse Station, N.J. Drugmaker Merck & Co. on Tuesday, April 21, posted a 57 percent drop in first-quarter profit, falling short of expectations, because of a drop in both...
View Photo »FILE - In this Sept. 30, 2004 file photo, an employee walks past a stained-glass window, bearing Merck & Co.'s name, as he walks to the elevator at the company's headquarters in a Whitehouse Station, N.J. Merck is one of the companies that lobbied successfully for a tax break enacted in...
View Photo »FILE -- In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington. From left are, Cedars-Sinai Health System President Thomas Priselac; Merck CEO Richard Clark; Kaiser Permanente CEO George...
View Photo »FILE - In this April 28, 2006 file photo, a bottle of Schering-Plough's allergy spray Nasonex is shown in New York. Schering-Plough, which is being bought by rival Merck & Co. , on Tuesday, July 21, 2009 said its profit jumped 49 percent in the second quarter, as the company recorded...
View Photo »FILE - In this May 11, 2009 file photo, President Barack Obama, center, speaks about health care in the State Dining Room of the White House in Washington. It was a watershed moment in this year's health care struggle: Leaders of the insurance, hospital and other medical industries...
View Photo »Richard Clark, Chairman and CEO of Merck attends a session at the World Economic Forum (WEF) in Davos January 29, 2010.
View Photo »In his 1995 annual letter to shareholders, Merck's chairman and CEO, Ray Gilmartin, delineated the company's number-one business objective as 'being a top-tier growth company'
Merck is making use of the currently good climate for corporate bonds
We are also pursuing partnering opportunities for our other product candidates, which could provide up-front and milestone payments, as well as funding of development costs and other licensing possibilities. In the event that we are unable to revise the Merck agreement, we would seek to raise additional...
We anticipate providing financial guidance for 2010 once we reach final agreement with our partner Merck on the terms of a revised collaboration agreement, including the scope of ridaforolimus development activities and the associated budget and funding
Although we cannot assure that such agreement will be reached, we have seen a strong commitment from Merck to bringing this process to fruition.
We are ready and eager to have our day in court and hold Merck responsible for the suffering it caused to thousands of women. Merck marketed this drug as a treatment for osteoporosis, when it knew the drug caused the death of bone tissue in the jaw. It’s a blatant example of the drug industry putting in...
inflames people against me. And wrongly. I’m in this for the same reason she is. I care about kids. Does she think that Merck is paying me to speak about vaccines? Is that the logic?
We think GTx will face increased near-term costs for Ostarine without Merck and might need to raise extra capital to pursue additional trials
It was a difficult decision to dissolve our SARM collaboration with Merck ... Reacquiring Ostarine moves us toward this objective by allowing us to advance our lead SARM into Phase III clinical studies in cancer cachexia, which is a large commercial opportunity for our company and a critical unmet medic...
We are extremely pleased to join Merck in advancing the science of reproductive medicine and contraceptive development, and thereby contribute to efforts aimed at reducing the number of unwanted pregnancies.
As a global company with a long history of dedication to public health, Merck is pleased to share its technical expertise with 21CB in this innovative approach to enhancing our nation's biodefense capabilities
Would the action against Johnson & Johnson give you pause to question Pfizer or Merck’s quality? ... Each generic company is separate and, just because one had a recall, it doesn’t mean they are all bad or that they have all fallen into an abyss.
spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period. The group's members include drug giants Pfizer Inc., Merck & Co., Johnson & Johnson and more than two dozen other U.S. and foreign companies.
It took Merck an entire year to respond
Merck acted responsibly in researching and developing FOSAMAX and in monitoring the medicine ever since it has been on the market. Our clinical trials, conducted both before and following approval, have involved more than 28,000 patients, including more than 17,000 treated with FOSAMAX.
Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth
The upcoming combination of Merial and Intervet/Schering-Plough is an exciting opportunity for sanofi-aventis to create with Merck a leading company in the Animal Health strategic and growing sector
Nothing is more important to Merck than the safety of its medicines
At present, integration of Millipore Corporation with Millipore India is going on and with the new development, the whole integration with Merck may take at least five to six months
It is unlikely that Merck will merge Millipore with the listed entity, Merck Ltd, and may merge it with the private entity, Merck Specialities
Merck and MSD Australia disagree with the limited portions of the court's findings that were against MSD Australia
Enough is enough. Time has come for Merck to do justice to these people
Merck may choose to appeal or they may decide to work towards a negotiated settlement that is satisfactory to clients and to the court
Merck was not negligent in its development, scientific study and sale of Vioxx.
While I do not make the allegation that it is a deliberate strategy on Merck's part, the economic reality of it is that Merck saves money every time [an injured Vioxx consumer] dies
